Shunsuke Yoshimine
Saitama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Potential therapeutic effects of adjuvant chemotherapy after neoadjuvant chemotherapy for locally advanced muscle-invasive bladder cancer.
Journal: Japanese journal of clinical oncology
Published: September 10, 2021
Oncological outcomes of dose reductions in cisplatin due to renal dysfunction for patients with metastatic urothelial carcinoma.
Journal: BJUI compass
Published: December 03, 2020
Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer.
Journal: Japanese journal of clinical oncology
Published: June 11, 2020
The pretreatment neutrophil-to-lymphocyte ratio is a novel biomarker for predicting clinical responses to pembrolizumab in platinum-resistant metastatic urothelial carcinoma patients.
Journal: Urologic oncology
Published: October 08, 2019
History of Non-Muscle-Invasive Bladder Cancer May Have a Worse Prognostic Impact in cT2-4aN0M0 Bladder Cancer Patients Treated With Radical Cystectomy.
Journal: Clinical genitourinary cancer
Published: November 16, 2017
Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy.
Journal: Medical oncology (Northwood, London, England)
Published: September 18, 2017
The prognostic significance of OCT4 expression in patients with prostate cancer.
Journal: Human pathology
Published: September 23, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026